Inflammatory bowel disease patient concerns and experiences on transition to home-based infusions during the COVID-19 pandemic.

ABSTRACT:

Background

In response to the COVID-19 pandemic, the CDC issued guidance advising patients and providers to adopt social distancing practices such as home-based infusions (H-BI).

Methods

We performed a mixed methods evaluation to summarize perceptions, concerns, and experiences with H-BI among all inflammatory bowel disease patients 18-90 years of age who transitioned to home-based infliximab or vedolizumab infusions between March to July 2020 at a tertiary care center. Semi-structured interviews were conducted and analyzed using an iterative, inductive thematic approach. Baseline characteristics and outcome on safety, COVID-19 transmission, delays in infusions, and H-BI persistence were collected.

Results

Of the 57 participants who transitioned to H-BI, 20 (33%) resp

SUBMITTER: Jacob J 

PROVIDER: S-EPMC9238022 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature